October 22, 2020
See original press release here
Toronto, Ontario — (Newsfile Corp. – October 22, 2020) – The Bloom Burton Healthcare Lending Trust (the “Fund”) was named a winner in multiple categories of the 2020 Canadian Hedge Fund Awards (CHFA). Bloom Burton Investment Group Inc. is the manager of the Fund and the Bloom Burton Canadian Healthcare Fund, alternative investment funds that focus on investments in the healthcare sector.
The Fund, a private debt fund, won two awards in the private debt category:
– Best 3-Year Return
– Best 5-Year Return
The Canadian Hedge Fund Awards, the highest honour in Canada’s hedge fund industry, help investors identify the most exceptional hedge funds, recognizing winners in five categories as well as the Overall Best 2020 Canadian Hedge Fund.
A total of 221 Canadian Hedge Funds were included in the 2020 CHFA program. The awards are based solely on quantitative performance data to June 30th, with Fundata Canada managing the collection and tabulation of the data to determine the winners. There is no nomination process or subjective assessment in identifying the winning hedge funds.
Michael Brown, CEO and Portfolio Manager of Bloom Burton Investment Group commented, “The real winners are the millions of people in Canada and beyond who will benefit from the healthcare innovation that our portfolio companies drive and is their focus in their daily work.”
The Bloom Burton Investment Group exists to provide investors with curated investment vehicles that deliver a diversified portfolio of healthcare companies in a single investment.
Bloom Burton Investment Group manages the Bloom Burton Canadian Healthcare Fund, which invests broadly in public healthcare securities and the Bloom Burton Healthcare Lending Trust, which makes long-term structured investments in private and public healthcare companies.
For further information, please contact:
Michael Brown, Portfolio Manager
About Bloom Burton & Co.
Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business strategy and scientific consulting, advisory on direct investing and company creation and incubation services. Please visit www.bloomburton.com to learn more.